Glax­o­SmithK­line R&D vet Min Li nabs $100M to launch a Bob Nelsen-backed start­up fo­cused on Chi­na’s bur­geon­ing neu­ro mar­ket

In re­cent years we’ve seen a whole string of Chi­na-based biotech star­tups gain im­pres­sive back­ing as they kick­start­ed new com­pa­nies with big plans in on­col­o­gy as they cre­at­ed pipelines and inked in­ter­na­tion­al li­cens­ing deals. Now GSK R&D vet and for­mer Johns Hop­kins pro­fes­sor Min Li plans to take much the same page on strat­e­gy and start some­thing big in neu­ro. And for now, he has this par­tic­u­lar field in Chi­na large­ly to him­self.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER